Henry Zhu is the CEO and President of BPS Bioscience, Inc., which he founded in 2005. Under his leadership, the company has grown into a global provider of recombinant proteins, assay kits, lentiviruses, cell lines, and screening services that accelerate drug discovery worldwide. With more than 20 years of experience in the biotechnology industry, Henry has led BPS Bioscience’s expansion into critical research areas such as immuno-oncology, autoimmune diseases, epigenetics, and cell signaling. His commitment to scientific excellence, innovation, and strategic partnerships has established BPS Bioscience as a trusted partner to both emerging biotech companies and leading global pharmaceutical organizations.